Oragenics Inc
OGEN· NYSE
OGENOragenics Inc
Filed May 15, 2013 · 10-Q · 45 days after period end · 0001193125-13-220866
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $176.41K | $380.53K | $349.94K |
| Net Income | -$1.59M | $1.62M | -$1.56M |
| EPS Diluted | -$0.06 | -$0.25 | -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end
